1. Home
  2. AVXL vs DEC Comparison

AVXL vs DEC Comparison

Compare AVXL & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • DEC
  • Stock Information
  • Founded
  • AVXL 2004
  • DEC 2001
  • Country
  • AVXL United States
  • DEC United States
  • Employees
  • AVXL N/A
  • DEC N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • DEC
  • Sector
  • AVXL Health Care
  • DEC
  • Exchange
  • AVXL Nasdaq
  • DEC Nasdaq
  • Market Cap
  • AVXL 794.0M
  • DEC 849.3M
  • IPO Year
  • AVXL N/A
  • DEC N/A
  • Fundamental
  • Price
  • AVXL $12.74
  • DEC $14.91
  • Analyst Decision
  • AVXL Strong Buy
  • DEC Strong Buy
  • Analyst Count
  • AVXL 2
  • DEC 4
  • Target Price
  • AVXL $44.00
  • DEC $20.75
  • AVG Volume (30 Days)
  • AVXL 1.2M
  • DEC 432.8K
  • Earning Date
  • AVXL 08-05-2025
  • DEC 01-01-0001
  • Dividend Yield
  • AVXL N/A
  • DEC 5.45%
  • EPS Growth
  • AVXL N/A
  • DEC N/A
  • EPS
  • AVXL N/A
  • DEC N/A
  • Revenue
  • AVXL N/A
  • DEC $758,798,000.00
  • Revenue This Year
  • AVXL N/A
  • DEC $46.42
  • Revenue Next Year
  • AVXL N/A
  • DEC $9.54
  • P/E Ratio
  • AVXL N/A
  • DEC N/A
  • Revenue Growth
  • AVXL N/A
  • DEC N/A
  • 52 Week Low
  • AVXL $4.93
  • DEC $10.08
  • 52 Week High
  • AVXL $14.44
  • DEC $17.70
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 69.01
  • DEC 56.99
  • Support Level
  • AVXL $10.98
  • DEC $14.24
  • Resistance Level
  • AVXL $11.33
  • DEC $15.15
  • Average True Range (ATR)
  • AVXL 0.75
  • DEC 0.33
  • MACD
  • AVXL 0.15
  • DEC 0.00
  • Stochastic Oscillator
  • AVXL 69.36
  • DEC 76.38

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About DEC Diversified Energy Company plc

Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.

Share on Social Networks: